The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Romero Uribe, Gabriela
Ye, JingYong
Funded by
NIH Natl Inst of Neuro Disorder/Stroke
Cell-type specific manipulation of neural circuits is required for the treatment of neurological disorders such as epilepsy and autism. Existing technologies to control neural activity offer limited possibilities. Manipulation of brain circuits via direct drug treatment is restricted by the selective permeability of the blood-brain barrier. the rapid clearance of cerebral fluids and the lack of specificity. which results in poor response to drugs and undesirable side effects.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Prevost, John
GaitIQ is an innovative Health Information Technology (HIT) company in San Antonio, Texas partnering with Southwest Research Institute (SwRI), UT Health San Antonio, and the University of Texas at San Antonio (UTSA). The goal of this SBIR grant is to demonstrate feasibility for a novel motion capture and gait analysis product to detect and monitor functional markers for neurodegenerative diseases and fall risk in primary care or community settings.